Atlanpole and SATT Ouest Valorisation consolidate their Deeptech plan in Pays de la Loire26 November 2020
Atlanpole, working alongside you to innovate
Valneva Initiates Phase 3 Clinical Trial for its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA200119.04.2021
Non-hormonal female contraception using antibody fragments22.03.2021
GoLiver Therapeutics is the winner of the French Government‘s «Recovery plan for the industry – strategic sectors» call for the implementation of its industrial manufacturing platform project aimed at developing a biomedicine from pluripotent stem cells
Since the end of 2015, the managers and collaborators of the Atlanpolitan companies have shared their business experiences through seminars and meetings. In this way, they have expanded their networks as well as their skills.